• De Boelelaan 1108, O|2 Lab Building (3E-09)

    1081 HZ Amsterdam

1977 …2018
If you made any changes in Pure these will be visible here soon.

Personal profile

Personal information

Nico P.E. Vermeulen (MSc in Chemistry (University of Nijmegen, NL, 1975) and a PhD in Pharmacology (University of Leiden, NL, 1980), was appointed professor of Molecular Toxicology in the Department of Chemistry and Pharmaceutical Sciences (CPS) at VU University Amsterdam, in 1985.

Employment (selected):

1975 Staff-member at the Subfaculty of Pharmacy, Univ. of Leiden, Leiden, NL; 1980 Senior staff-member Center for Bio-Pharmaceutical Sciences, Univ. of Leiden, Leiden; 1985 Professor of Molecular Toxicology, Section of Molecular Toxicology, Vrije  Universiteit, Amsterdam, NL (www.moltox.chem.vu.nl ; 1985 - ); 1997 Dean Faculty of Chemistry, Vrije Universiteit (1997 - 2000); 2005 Scientific Director Leiden-Amsterdam Center for Drug Research (LACDR) (2005-‘11); 2010 Coordinator/ Manager IMI-SafeSciMET: ‘Modular Education and Training programme for Translational Safety Sciences for Medicines’ (2010 - ‘17); 2010 Head Department of Chemistry and Pharmaceutical Sciences (CPS), Vrije Universiteit (2010 - ‘15); 2010 Director Amsterdam Institute for Molecules, Medicines & Systems, Vrije Universiteit (AIMMS, www.aimms.vu.nl ; 2010 -).

His general research interests are concerned with the roles molecular and computational toxicology can play in drug discovery, development and safety assessment. More specifically, he is interested in toxication/detoxication mechanisms, in silico and in vitro prediction and screening of ADME-Tox properties, (biocatalytic) metabolite production and profiling and translational biomarkers of adverse drug reactions (ADRs).

He is author / co-author of more than 400 scientific publications in the fields of molecular toxicology / pharmacology, bioanalysis and medicinal chemistry. In 2010 and 2015, he was listed as highly-cited author at www.ISIhighlycited.com. He has been promotor/supervisor of > 50 PhD-students.

Selected professional activities:

** President-elect (2000-2001), President (2002 - 2003) and Past-president (2004 - 2005) of ISSX, the International Society for the Study of Xenobiotics; ** Joint 19th Microsomes & Drug Oxidation (MDO) / 12th European ISSX meeting, 17-21 June, 2012, Noordwijk aan Zee, The Netherlands (Chairman); ** Coordinator / Managing Entity IMI-JU programme SafeSciMET, a European Modular Education & Training Programme in Safety Sciences for Medicines (2010 – 2017);

** Editor / Editor in Chief of Environmental Toxicology & Pharmacology (1997 - / 2001 - ); ** Associate-editor of Biomarkers (1996 - 2008), Current Drug Metabolism (2007 -) and Drug Metabolism Letters (2007 -); ** Member of Editorial Boards of: Biochem. Pharmacol., J Biomed. & Environm. Sci., Chem. & Biodiversity, Chemico-Biol. Interact., Chem. Res. Toxicol., Chirality, Drug Metab. Rev., Expert Opinions Drug Metab. & Toxicol., Toxicol. and Xenobiotica


Prizes and Awards

Recognitions (selected):

1985 Officially registered as Toxicologist (at SMBWO and NVT (1988, 2013, per 5 years);  1987 Anna DiCarlo Award (Best platform paper, ISSX/SOT Meeting, Sarasota, USA);  2004 Honorary membership of ISSX (2004, lifetime);  2006 European ISSX Scientific Achievement Award 2006, Manchester, UK;  2006 Ernst Schering Lecturer, Ernst Schering Research Foundation, Berlin, Germany;  2011 Honorary doctorate University of Copenhagen, via Faculty of Pharmaceutical Sciences;  2016 Distinguished ISSX Service Achievement Award 2016, ISSX Busan, South Korea.


1975 Degree in Chemistry (M.Sc.) Catholic University of Nijmegen, NL (Pharmacology & Org. Chemistry (Nijmegen), Mass Spectrometry (Univ. Amsterdam)

1980 Ph.D.-degree in Bio-Pharmaceutical Sciences, Univ. of Leiden. Supervisors: Prof. dr. D.D. Breimer and Prof. dr. H.J. de Jong. Thesis: The epoxide-diol pathway in the metabolism of Hexobarbital and related Barbiturates

Ancillary activities

No ancillary activities

Ancillary activities are updated daily


  • QD Chemistry
  • drug discovery
  • drug development
  • Drug safety
  • RM Therapeutics. Pharmacology
  • Drug safety
  • Drug metabolism
  • Toxicology

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Cytochrome P-450 Enzyme System Medicine & Life Sciences
Rats Chemical Compounds
Metabolites Chemical Compounds
Cytochrome P-450 CYP2D6 Medicine & Life Sciences
Liver Chemical Compounds
Glutathione Transferase Medicine & Life Sciences
Acetaminophen Medicine & Life Sciences
Metabolism Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1977 2018

Amino Acid Transport Systems
Cytochrome P-450 Enzyme System

Drug induced liver injury: assessment of inter-individual variation in the balance of bioactivation and inactivation as risk factor

den Braver, M. W. 2018 288 p.

Research output: ThesisPhD Thesis - Research VU, graduation VU

Open Access
Drug-Related Side Effects and Adverse Reactions
Saccharomyces cerevisiae

Effect of UGT2B7*2 and CYP2C8*4 polymorphisms on diclofenac metabolism

Lazarska, K. E., Dekker, S. J., Vermeulen, N. P. E. & Commandeur, J. N. M. 1 Mar 2018 In : Toxicology Letters. 284, 1 March, p. 70-78 9 p.

Research output: Contribution to journalArticle

Open Access
Chemical and Drug Induced Liver Injury